Research
NeuroIntact is engaged in research and development across quantitative pupillometry, electrophysiology, and multimodal neurological diagnostics. The following areas represent investigational work and do not reflect cleared or approved indications.
01 / Research areas
NeuroIntact's research program spans several neurological conditions and diagnostic modalities. All work described below is investigational.
Investigating the role of quantitative pupillometry in the assessment of patients with traumatic brain injury. Research explores whether objective, repeatable pupil measurements may support clinical monitoring in TBI care settings.
Investigational — not cleared or approved for TBI diagnosis or monitoring.
Exploring quantitative pupillary assessment as a potential tool in stroke-related neurological monitoring. Research examines whether objective pupil data may complement existing clinical evaluation in stroke care.
Investigational — not cleared or approved for stroke diagnosis or monitoring.
Investigating whether quantitative pupil measurements may provide clinically relevant information in conditions associated with brain edema and elevated intracranial pressure. Research is ongoing and findings are preliminary.
Investigational — not cleared or approved for brain edema or ICP assessment.
Exploring the integration of electrophysiological measurements with quantitative pupillometry as part of a multimodal approach to neurological assessment. This work is part of the broader NVI platform research program.
Investigational — electrophysiology integration is not part of any currently cleared product.
02 / NeuroVAL
NeuroVAL Program
NeuroVAL is NeuroIntact's internal research and validation program. It provides a structured framework for evaluating the performance characteristics of quantitative neurological assessment technologies across clinical and investigational settings.
NeuroVAL is an investigational program. Data and findings generated through NeuroVAL have not been cleared or approved by the FDA and are not intended to support clinical decision-making outside of approved research protocols.
03 / Collaboration
NeuroIntact welcomes collaboration with clinical researchers, academic medical centers, and neurological care teams interested in quantitative pupillometry and multimodal neurological diagnostics.
Regulatory disclosure. All research described on this page is investigational. NeuroIntact's research program does not constitute cleared or approved indications for any NeuroIntact product. Research findings are preliminary and subject to change. Nothing on this page should be interpreted as a claim of clinical efficacy or regulatory clearance.